Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 3
1969 4
1970 2
1972 1
1973 1
1974 3
1975 1
1976 1
1978 1
1979 3
1980 1
1982 4
1983 2
1984 3
1985 1
1986 1
1987 3
1988 2
1990 7
1991 2
1992 3
1993 5
1994 5
1995 11
1996 18
1997 8
1998 10
1999 7
2000 14
2001 5
2002 7
2003 8
2004 9
2005 8
2006 9
2007 8
2008 7
2009 5
2010 2
2011 5
2012 2
2013 5
2014 5
2015 7
2016 6
2017 3
2018 3
2019 3
2020 7
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Results by year
Filters applied: . Clear all
Page 1
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LM, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RH, Toller W, Tritapepe L, Tschöpe C, Wikström G, von Lewinski D, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: papp jg. Card Fail Rev. 2020 Jul 8;6:e19. doi: 10.15420/cfr.2020.03. eCollection 2020 Mar. Card Fail Rev. 2020. PMID: 32714567 Free PMC article. Review.
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: papp jg. J Cardiovasc Pharmacol. 2020 Jul;76(1):4-22. doi: 10.1097/FJC.0000000000000859. J Cardiovasc Pharmacol. 2020. PMID: 32639325 Free PMC article. Review.
Antiarrhythmic compounds.
Szekeres L, Papp JG. Szekeres L, et al. Among authors: papp jg. Prog Drug Res. 1968;12:292-369. doi: 10.1007/978-3-0348-7065-8_5. Prog Drug Res. 1968. PMID: 4389462 Review. No abstract available.
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Follath F, et al. Among authors: papp jg. Lancet. 2002 Jul 20;360(9328):196-202. doi: 10.1016/s0140-6736(02)09455-2. Lancet. 2002. PMID: 12133653 Clinical Trial.
Blockade of sodium‑calcium exchanger via ORM-10962 attenuates cardiac alternans.
Szlovák J, Tomek J, Zhou X, Tóth N, Veress R, Horváth B, Szentandrássy N, Levijoki J, Papp JG, Herring N, Varró A, Eisner DA, Rodriguez B, Nagy N. Szlovák J, et al. Among authors: papp jg. J Mol Cell Cardiol. 2021 Apr;153:111-122. doi: 10.1016/j.yjmcc.2020.12.015. Epub 2020 Dec 28. J Mol Cell Cardiol. 2021. PMID: 33383036 Free PMC article.
Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P. Ziegler D, et al. Among authors: papp jg. J Cardiovasc Pharmacol. 1996;27 Suppl 3:S26-37. doi: 10.1097/00005344-199627003-00005. J Cardiovasc Pharmacol. 1996. PMID: 8872297 Review.
234 results